SCHEMBL13033693

SCHEMBL13033693

C/C(=N/OS(=O)(=O)c1ccc(C)cc1)c1ccc(C(=O)O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 1/20 0.51
ALDH1A1 P00352 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
SRD5A2 P31213 1/20 0.46
GFER P55789 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPT P10636 3/20 0.45
GAA P10253 2/20 0.45
CYP1A2 P05177 1/20 0.44
TDP1 Q9NUW8 2/20 0.44
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
NPSR1 Q6W5P4 2/20 0.43
G6PD P11413 1/20 0.43
TAS2R14 Q9NYV8 2/20 0.43
F2 P00734 1/20 0.41
PRSS1 P07477 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31565026 0.88 LMNA (0.46) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL92088 0.88 LMNA (0.46) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL13461573 0.86 SMN1; SMN2 (0.42) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL14395720 0.85 CYP1A2 (0.58) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
Nitrous Acid SCHEMBL6396171 0.84 LMNA (0.43) ALDH1A1MEN1KMT2AMAPTTDP1
SCHEMBL13567344 0.84 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AMAPTGAA
Nitrous Acid SCHEMBL6396175 0.84 LMNA (0.43) ALDH1A1MEN1KMT2AMAPTTDP1
SCHEMBL7296409 0.82 MAPT (0.53) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL7296406 0.82 MAPT (0.53) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL28165142 0.82 MAPT (0.53) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298168-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions HK PHARMACEUTICALS, INC. 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298168-A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions CHLSN, PTMS, SRMS STAT3 3992/4885ALDH1A1 4064/4885SMN1; SMN2 3130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.